Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 10 June 2016 | By Zachary Brennan
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) on Friday announced that it has put on hold the addition of Indian contract manufacturing organization (CMO) Akums Drugs' Haridwar-based site as a manufacturing facility for the marketing authorization of Nordic Pharma's hormone injection progesterone due to a lack of sterility assurance.
An MHRA inspection of the site (its first inspection for the site) on 13 April revealed one critical and three major deficiencies.
“The critical deficiency was for lack of sterility assurance, as there was insufficient evidence during validation to confirm that all ampoules in the load met the sterilising conditions of 160oC for 2 hours, a weak sterility sampling plan and lack of qualification of the leak test cycle, MHRA said.
The major deficiencies were for inadequate control and validation of sterilisation, deficiencies across all aspects of the quality management system and lack of a robust environmental monitoring programme. 13 other deficiencies covering all aspects of GMP were recorded but not formally reported so as not to distract from the critical and major deficiencies.
The UK regulator noted that the site currently manufactures some unlicensed progesterone injections supplied to the UK and Ireland, and four batches will be recalled, although there is little stock expected on the market.
A notification to healthcare practitioners has been issued, MHRA said, noting that additional monitoring should be considered. Neither Nordic Pharma nor Akums responded to requests for comment.
EudraGMDP
Tags: Nordic Pharma, notice of concern, Akums Drugs, Indian drug manufacturing
Regulatory Focus newsletters
All the biggest regulatory news and happenings.